Inflammation in the context of oral cancer

Oral Oncology

Volumn 49, Issue 9, 2013, Pages 887-892

  Feller, L ^a   Altini, M ^b   Lemmer, J ^a  

^a SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

AP 1; Cancer associated inflammation; COX 2; NF B; Oral lichen planus; Oral squamous cell carcinoma; Oral submucous fibrosis; STAT 3

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CELL ADHESION MOLECULE; CYCLIN D; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR 2; FLICE INHIBITORY PROTEIN; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MATRILYSIN; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; PROTEIN BCL 2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SCLEROPROTEIN; STAT3 PROTEIN; SURVIVIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ALCOHOL CONSUMPTION; APOPTOSIS; BACTERIAL INFECTION; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CHRONIC INFLAMMATION; CHRONIC PERIODONTITIS; CYTOTOXIC T LYMPHOCYTE; DNA DAMAGE; DNA REPAIR; ENVIRONMENTAL FACTOR; FIBROBLAST; FIBROSIS; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; KERATINOCYTE; LICHEN PLANUS; MACROPHAGE; MALIGNANT TRANSFORMATION; MAST CELL; METASTASIS; MONOCYTE; MOUTH INFLAMMATION; MOUTH SQUAMOUS CELL CARCINOMA; MYELOID DENDRITIC CELL; NATURAL KILLER T CELL; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN DNA INTERACTION; REVIEW; SMOKING; TOOTH PLAQUE; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; WOUND HEALING;

AP-1; CANCER-ASSOCIATED INFLAMMATION; COX-2; NF-ΚB; ORAL LICHEN PLANUS; ORAL SQUAMOUS CELL CARCINOMA; ORAL SUBMUCOUS FIBROSIS; STAT-3;

CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; HUMANS; INFLAMMATION; MOUTH NEOPLASMS; WOUND HEALING;

EID: 84883133097     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.07.003     Document Type: Review

References (66)

1. S.P. Hussain, and C.C. Harris Inflammation and cancer: an ancient link with novel potentials Int J Cancer 121 11 2007 2373 2380
2. I.L. Aivaliotis, I.S. Pateras, M. Papaioannou, C. Glytsou, K. Kontzoglou, and E.O. Johnson How do cytokines trigger genomic instability? J Biomed Biotechnol 2012 2012 536761
3. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 7 2009 1073 1081
4. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 2011 646 674
5. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 7203 2008 436 444
6. A. Mantovani Molecular pathways linking inflammation and cancer Curr Mol Med 10 4 2010 369 373
7. W.W. Lin, and M. Karin A cytokine-mediated link between innate immunity, inflammation, and cancer J Clin Invest 117 5 2007 1175 1183
8. M. Schafer, and S. Werner Cancer as an overhealing wound: an old hypothesis revisited Nat Rev Mol Cell Biol 9 8 2008 628 638
9. M.M. Moore, W. Chua, K.A. Charles, and S.J. Clarke Inflammation and cancer: causes and consequences Clin Pharmacol Ther 87 4 2010 504 508
10. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 6917 2002 860 867
11. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 6 2010 883 899
12. B.B. Aggarwal, and P. Gehlot Inflammation and cancer: how friendly is the relationship for cancer patients? Curr Opin Pharmacol 9 4 2009 351 369
13. J.I. Kim, V. Lakshmikanthan, N. Frilot, and Y. Daaka Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome Mol Cancer Res 8 4 2010 569 577
14. Z. Chen, X. Zhang, M. Li, Z. Wang, H.S. Wieand, and J.R. Grandis Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck Clin Cancer Res 10 17 2004 5930 5939
15. A.J. Dannenberg, S.M. Lippman, J.R. Mann, K. Subbaramaiah, and R.N. DuBois Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention J Clin Oncol 23 2 2005 254 266
16. A. Futagami, M. Ishizaki, Y. Fukuda, S. Kawana, and N. Yamanaka Wound healing involves induction of cyclooxygenase-2 expression in rat skin Lab Invest 82 11 2002 1503 1513
17. L.J. Wirth, R.I. Haddad, N.I. Lindeman, X. Zhao, J.C. Lee, and V.A. Joshi Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck J Clin Oncol 23 28 2005 6976 6981
18. L. Lalier, F. Pedelaborde, C. Braud, J. Menanteau, F.M. Vallette, and C. Olivier Increase in intracellular PGE2 induces apoptosis in Bax-expressing colon cancer cell BMC Cancer 11 2011 153
19. F.G. Buchanan, D. Wang, F. Bargiacchi, and R.N. DuBois Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor J Biol Chem 278 37 2003 35451 35457
20. E. Vacchelli, L. Galluzzi, A. Eggermont, J. Galon, E. Tartour, and L. Zitvogel Trial Watch: Immunostimulatory cytokines Oncoimmunology 1 4 2012 493 506
21. M. Karin, T. Lawrence, and V. Nizet Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer Cell 124 4 2006 823 835
22. M. Fukata, A. Chen, A. Klepper, S. Krishnareddy, A.S. Vamadevan, and L.S. Thomas Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine Gastroenterology 131 3 2006 862 877
23. H. Xiao, M.F. Gulen, J. Qin, J. Yao, K. Bulek, and D. Kish The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis Immunity 26 4 2007 461 475
24. M. Kojima, T. Morisaki, K. Izuhara, A. Uchiyama, Y. Matsunari, and M. Katano Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation Oncogene 19 9 2000 1225 1231
25. S. Choi, and J.N. Myers Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy J Dent Res 87 1 2008 14 32
26. J.A. Goulart Filho, C.F. Nonaka, M.C. da Costa Miguel, R. de Almeida Freitas, and H.C. Galvao Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma Am J Otolaryngol 30 2 2009 89 94
27. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 11 2002 549 555
28. M. Egeblad, E.S. Nakasone, and Z. Werb Tumors as organs: complex tissues that interface with the entire organism Dev Cell 18 6 2010 884 901
29. B.Z. Qian, and J.W. Pollard Macrophage diversity enhances tumor progression and metastasis Cell 141 1 2010 39 51
30. A. Sica, T. Schioppa, A. Mantovani, and P. Allavena Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy Eur J Cancer 42 6 2006 717 727
31. S.B. Coffelt, A.O. Tal, A. Scholz, M. De Palma, S. Patel, and C. Urbich Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions Cancer Res 70 13 2010 5270 5280
32. C.E. Lewis, M. De Palma, and L. Naldini Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2 Cancer Res 67 18 2007 8429 8432
33. S. Ostrand-Rosenberg, and P. Sinha Myeloid-derived suppressor cells: linking inflammation and cancer J Immunol 182 8 2009 4499 4506
34. S. Nagaraj, and D.I. Gabrilovich Tumor escape mechanism governed by myeloid-derived suppressor cells Cancer Res 68 8 2008 2561 2563
35. M.H. Manjili, and K.K. Payne Cancer immunotherapy: re-programming cells of the innate and adaptive immune systems Oncoimmunology 1 2 2012 201 204
36. M. Johansson, D.G. Denardo, and L.M. Coussens Polarized immune responses differentially regulate cancer development Immunol Rev 222 2008 145 154
37. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 9255 2001 539 545
38. D.F. Legler, M. Bruckner, E. Uetz-von Allmen, and P. Krause. Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances Int J Biochem Cell Biol 42 2 2010 198 201
39. O.J. Finn Cancer immunology N Engl J Med 358 25 2008 2704 2715
40. J. Lemmer, and M. Shear Oral submucous fibrosis. A possible case in a person of Caucasian descent Br Dent J 122 8 1967 343 346
41. R. Rajendran Oral submucous fibrosis: etiology, pathogenesis, and future research Bull World Health Organ 72 6 1994 985 996
42. P. Rajalalitha, and S. Vali Molecular pathogenesis of oral submucous fibrosis-a collagen metabolic disorder J Oral Pathol Med 34 6 2005 321 328
43. C.P. Chiang, H.Y. Wu, B.Y. Liu, J.T. Wang, and M.Y. Kuo Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan Oral Oncol 38 1 2002 56 63
44. M.F. Haque, M. Harris, S. Meghji, and A.W. Barrett Immunolocalization of cytokines and growth factors in oral submucous fibrosis Cytokine 10 9 1998 713 719
45. C.J. Chiu, C.P. Chiang, M.L. Chang, H.M. Chen, L.J. Hahn, and L.L. Hsieh Association between genetic polymorphism of tumor necrosis factor-alpha and risk of oral submucous fibrosis, a pre-cancerous condition of oral cancer J Dent Res 80 12 2001 2055 2059
46. J.H. Jeng, Y.J. Wang, B.L. Chiang, P.H. Lee, C.P. Chan, and Y.S. Ho Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline Carcinogenesis 24 8 2003 1301 1315
47. S. Khan, L. Chatra, S.K. Prashanth, K.M. Veena, and P.K. Rao Pathogenesis of oral submucous fibrosis J Cancer Res Ther 8 2 2012 199 203
48. W.A. Border, and N.A. Noble Transforming growth factor beta in tissue fibrosis N Engl J Med 331 19 1994 1286 1292
49. L. Feller, and J. Lemmer Oral Squamous cell carcinoma: epidemiology, clinical presentation and treatment J Cancer Ther 3 4 2012 263 268
50. U. Mattsson, M. Jontell, and P. Holmstrup Oral lichen planus and malignant transformation: is a recall of patients justified? Crit Rev Oral Biol Med 13 5 2002 390 396
51. M.A. Gonzalez-Moles, C. Scully, and J.A. Gil-Montoya Oral lichen planus: controversies surrounding malignant transformation Oral Dis 14 3 2008 229 243
52. F.A. Sousa, T.C. Paradella, A.A. Brandao, and L.E. Rosa Oral lichen planus versus epithelial dysplasia: difficulties in diagnosis Braz J Otorhinolaryngol 75 5 2009 716 720
53. Y. Liu, D.V. Messadi, H. Wu, and S. Hu Oral lichen planus is a unique disease model for studying chronic inflammation and oral cancer Med Hypotheses 75 6 2010 492 494
54. C. Scully, M. Beyli, M.C. Ferreiro, G. Ficarra, Y. Gill, and M. Griffiths Update on oral lichen planus: etiopathogenesis and management Crit Rev Oral Biol Med 9 1 1998 86 122
55. M.D. Mignogna, S. Fedele, L. Lo Russo, L. Lo Muzio, and E. Bucci Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence ? Oral Oncol 40 2 2004 120 130
56. T.J. Li, and J. Cui COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma Asian Pac J Trop Med 6 8 2013 640 643
57. E.A. Georgakopoulou, M.D. Achtari, M. Achtaris, P.G. Foukas, and A. Kotsinas Oral lichen planus as a preneoplastic inflammatory model J Biomed Biotechnol 2012 2012 759626
58. Y. Nakano, W. Kobayashi, S. Sugai, H. Kimura, and S. Yagihashi Expression of tumor necrosis factor-alpha and interleukin-6 in oral squamous cell carcinoma Jpn J Cancer Res 90 8 1999 858 866
59. N. Oyama, K. Iwatsuki, Y. Homma, and F. Kaneko Induction of transcription factor AP-2 by inflammatory cytokines in human keratinocytes J Invest Dermatol 113 4 1999 600 606
60. J. Massano, F.S. Regateiro, G. Januario, and A. Ferreira Oral squamous cell carcinoma: review of prognostic and predictive factors Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 1 2006 67 76
61. M.S. Meyer, K. Joshipura, E. Giovannucci, and D.S. Michaud A review of the relationship between tooth loss, periodontal disease, and cancer Cancer Causes Control 19 9 2008 895 907
62. M. Tezal, M.A. Sullivan, A. Hyland, J.R. Marshall, D. Stoler, and M.E. Reid Chronic periodontitis and the incidence of head and neck squamous cell carcinoma Cancer Epidemiol Biomarkers Prevent 18 9 2009 2406 2412
63. M. Tezal, M. Sullivan Nasca, D.L. Stoler, T. Melendy, A. Hyland, and P.J. Smaldino Chronic periodontitis-human papillomavirus synergy in base of tongue cancers Arch Otolaryngol Head Neck Surg 135 4 2009 391 396
64. S.J. Hooper, M.J. Wilson, and S.J. Crean Exploring the link between microorganisms and oral cancer: a systematic review of the literature Head Neck 31 9 2009 1228 1239
65. C. Scully, and J. Bagan Oral squamous cell carcinoma overview Oral Oncol 45 4-5 2009 301 308
66. M. Bloching, W. Reich, J. Schubert, T. Grummt, and A. Sandner The influence of oral hygiene on salivary quality in the Ames test, as a marker for genotoxic effects Oral Oncol 43 9 2007 933 939